Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

ClinicalTrials.gov ID: NCT05369403

Public ClinicalTrials.gov record NCT05369403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 11:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Evaluate the Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Study identification

NCT ID
NCT05369403
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
86 participants

Conditions and interventions

Interventions

  • Lebrikizumab Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2022
Primary completion
Jan 10, 2024
Completion
Feb 4, 2025
Last update posted
Feb 24, 2026

2022 – 2025

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
River Region Dermatology and Laser Montgomery Alabama 36117
Medical Dermatology Specialists Phoenix Arizona 85006
First OC Dermatology Fountain Valley California 92708
Axon Clinical Research Inglewood California 90301
Avance Clinical Trials Inc Laguna Niguel California 92677
Dermatology Research Associates Los Angeles California 90045
Wallace Medical Group, Inc. Los Angeles California 90056
Clinical Science Institute Santa Monica California 90404
Cura Clinical Research Sherman Oaks California 91403
UConn Health Farmington Connecticut 06030-2840
Encore Medical Research of Boynton Beach Boynton Beach Florida 33436
Total Vein and Skin LLC Boynton Beach Florida 33437
Direct Helpers Research Center Hialeah Florida 33012
Hollywood Dermatology Hollywood Florida 33021
Miami Dermatology and Laser Research Miami Florida 33173
Ziaderm Research, LLC. North Miami Beach Florida 33162
Olympian Clinical Research Tampa Florida 33615
Skin Care Physicians of Georgia Macon Georgia 31217
Advanced Medical Research Sandy Springs Georgia 30328
Dundee Dermatology West Dundee Illinois 60118
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
Dermatology and Advanced Aesthetics Lake Charles Louisiana 70605
Dermatology and Skin Cancer Specialists, LLC Rockville Maryland 20850
Allcutis Research, Inc. Beverly Massachusetts 01915
Oakland Hills Dermatology Auburn Hills Michigan 48326
The Derm Institute of West Michigan Caledonia Michigan 49316
Revival Research Institute - Troy Troy Michigan 48084
MediSearch Clinical Trials Saint Joseph Missouri 64506
Allcutis Research, Inc Portsmouth New Hampshire 03801
Windsor Dermatology, P.C. East Windsor New Jersey 08520
Sadick Research Group New York New York 10075
OptiSkin Medical New York New York 10128
Dermatologists of Greater Columbus Bexley Ohio 43209
Dermatology and Skin Surgery Center, PC Exton Pennsylvania 19341
Clinical Partners, LLC Johnston Rhode Island 02919
Complete Dermatology Sugar Land Texas 77479
Spokane Dermatology Clinic Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05369403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2026 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05369403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →